LATE-BREAKING ABSTRACT: Circulating collagen indices indicative of disease severity in pulmonary arterial hypertension

Z. Safdar (Houston, United States Of America)

Source: Annual Congress 2012 - New insights in pneumology - ERS inter-Assemblies late-breaking abstracts
Session: New insights in pneumology - ERS inter-Assemblies late-breaking abstracts
Session type: Thematic Poster Session
Number: 2735
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Z. Safdar (Houston, United States Of America). LATE-BREAKING ABSTRACT: Circulating collagen indices indicative of disease severity in pulmonary arterial hypertension. Eur Respir J 2012; 40: Suppl. 56, 2735

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Evidence for a critical contribution of pericytes in pulmonary arterial hypertension pathogenesis
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Fibrinogen plasma levels and disease severity in pulmonary artery hypertension
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



Circulating collagen biomarker and quality of life in pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

Soluble LR11 level is correlated with the severity of pulmonary hypertension due to left heart disease.
Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension
Year: 2020


Arterial stiffness in patients with chronic obstructive pulmonary disease combined with arterial hypertension
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020


Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011

Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 210-212
Year: 2012


Circulating fibrocytes in pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011


Circulating fibrocytes and pulmonary arterial hypertension
Source: Eur Respir J 2011; 39: 210-212
Year: 2012


Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia
Source: International Congress 2017 – PAH and CTEPH
Year: 2017


Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment
Source: Eur Respir Rev 2014; 23: 505-509
Year: 2014


Plasma big-endothelin and hemodynamics in patients with pulmonary arterial hypertension compared to patients with chronic left heart failure with and without pulmonary venous hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Increased arterial stiffness in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 65s
Year: 2006

C-reactive protein and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease with pulmonary arterial hypertension
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010

Low T3-syndrome and respiratory muscle dysfunction in patients with pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 545s
Year: 2006

Determinants and prognostic value of kidney disease in pulmonary arterial hypertension
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018


Assessment of the BODE index, arterial stiffness and endothelial dysfunction in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012

Increased platelet reactivity and thrombogenesis in pulmonary arterial hypertension subgroups
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009


LATE-BREAKING ABSTRACT: The effect of volume overload on pulmonary hypertension in hemodialysis patients
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015